A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China
Clinical trial NCT04894890 · COMPLETED
Trial details
- NCT number
- NCT04894890
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-26
- Primary completion
- 2023-12-15
- Enrollment
- 1002
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.